New York State Common Retirement Fund increased its position in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) by 17.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 278,548 shares of the company's stock after purchasing an additional 42,368 shares during the period. New York State Common Retirement Fund owned 0.44% of Guardian Pharmacy Services worth $5,643,000 at the end of the most recent quarter.
Other institutional investors also recently bought and sold shares of the company. R Squared Ltd purchased a new position in Guardian Pharmacy Services in the fourth quarter worth approximately $30,000. Investment Research & Advisory Group Inc. purchased a new position in shares of Guardian Pharmacy Services during the 4th quarter worth $34,000. Compass Financial Services Inc acquired a new stake in shares of Guardian Pharmacy Services during the 4th quarter worth about $58,000. Rhumbline Advisers purchased a new stake in Guardian Pharmacy Services in the 4th quarter valued at about $149,000. Finally, Stephens Inc. AR purchased a new stake in Guardian Pharmacy Services in the 3rd quarter valued at about $189,000.
Wall Street Analyst Weigh In
Separately, Truist Financial boosted their target price on Guardian Pharmacy Services from $22.00 to $24.00 and gave the company a "buy" rating in a research report on Friday, November 15th.
Check Out Our Latest Stock Analysis on GRDN
Guardian Pharmacy Services Stock Performance
Shares of GRDN stock traded down $1.00 during mid-day trading on Monday, hitting $19.01. 30,401 shares of the stock were exchanged, compared to its average volume of 68,922. The firm's fifty day moving average price is $20.83. Guardian Pharmacy Services, Inc. has a 12-month low of $14.16 and a 12-month high of $25.74.
About Guardian Pharmacy Services
(
Free Report)
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Recommended Stories
Before you consider Guardian Pharmacy Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.
While Guardian Pharmacy Services currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
